Table 5.
A. | |||
---|---|---|---|
Factor | Cases (n=42) | Controls (n=84) | P-value* |
LOS† in days (median, range) | 19.5 (5–84) | 9.5 (4–36) | <0.001 |
Unplanned ICU admission | 15 (35.7%) | 10 (11.9%) | |
OR=4.79, 95% | CI 1.70–13.48 | 0.003 | |
Ability to start chemotherapy | 29/41 (70.7%) | 69/75 (92%) | |
OR=0.31, 95% | CI 0.11–0.83 | 0.020 | |
TTC ≤30 days | 5/41 (12.2%) | 25/72 (34.7%) | 0.027 |
OR=0.28, 95% | CI 0.09–0.87 | ||
TTC† (median, range) | 47.5 (25–92) | 35.0 (14–136) | 0.007 |
30-day mortality | 1 (2.4%) | 2 (2.4%) | -‡ |
90-day mortality | 8 (19.1%) | 6 (7.1%) | 0.061 |
| |||
B. | |||
Factor | Stoma (n=9) | No stoma (n=75) | P-value# |
| |||
LOS† in days (median, range) | 11 (7.3) | 9 (6.0) | 0.26 |
Unplanned ICU admission | 3 (33.3%) | 7 (9.3%) | 0.07 |
Ability to start chemotherapy | 8/8 (100%) | 61/67 (91%) | 1.00 |
TTC† (median, range) | 36.5 (30–54) | 34 (14–136) | 0.29 |
30-day mortality | 0 (0%) | 2 (2.7%) | 1.00 |
90-day mortality | 1 (11.1%) | 5 (6.8%) | 0.51 |
P-value from stratified conditional logistic regression models
Hospital length of stay (LOS); time to chemotherapy (TTC)
Too few events to compare
Continuous variables: Wilcoxon rank sum test; categorical variables: Chi-square test